Medpace Holdings, Inc. Effective Income Tax Rate Reconciliation Fdii Amount
Medpace Holdings, Inc. (MEDP) reported Effective Income Tax Rate Reconciliation Fdii Amount of $2.17 million for the 12-month period ending 2025-12-31, per its 10-K filed 2026-02-10.
Financial Statements › Expense Statement › Income Tax
us-gaap:EffectiveIncomeTaxRateReconciliationFdiiAmount · last filed 2026-02-10
- Medpace Holdings, Inc. effective income tax rate reconciliation fdii amount for fiscal 2025 was $2.17M, a 80.10% decline from fiscal 2024.
- Medpace Holdings, Inc. effective income tax rate reconciliation fdii amount for fiscal 2024 was $10.93M, a 16.81% increase from fiscal 2023.
- Medpace Holdings, Inc. effective income tax rate reconciliation fdii amount for fiscal 2023 was $9.36M, a 87.80% increase from fiscal 2022.
- Medpace Holdings, Inc. effective income tax rate reconciliation fdii amount for fiscal 2022 was $4.98M, a 2.53% increase from fiscal 2021.
| Period end | Effective Income Tax Rate Reconciliation Fdii Amount 12 month |
|---|---|
| 2025-12-31 | $2.17M 10-K · filed 2026-02-10 |
| 2024-12-31 | $10.93M 10-K · filed 2026-02-10 |
| 2023-12-31 | $9.36M 10-K · filed 2026-02-10 |
| 2022-12-31 | $4.98M 10-K · filed 2025-02-11 |
| 2021-12-31 | $4.86M 10-K · filed 2024-02-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL) | United States | $14.060B | -43.97 |
| INCYTE CORP (INCY) | United States | $24.855B | 13.14 |
| Absci Corp (ABSI) | United States | $1.775B | -14.92 |
| OmniAb, Inc. (OABI) | United States | $0.698B | -8.05 |
| NRC HEALTH (NRC) | United States | $0.450B | 42.50 |
| MAXCYTE, INC. (MXCT) | United States | $0.124B | -3.68 |
| bioAffinity Technologies, Inc. (BIAF) | United States | $0.063B | |
| OneMedNet Corp (ONMD) | $0.042B | ||
| iSpecimen Inc. (ISPC) | United States | $0.003B | |
| FOXO TECHNOLOGIES INC. (FOXO) | United States | $0.000B | -277.71 |